The economic impact of chronic obstructive pulmonary disease

Author： Hilleman Daniel E   Faulkner Michele A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.3, 2002-03, pp. : 219-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options

By Friedman M.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 245-254

Adis International

Access to resources Recommend Favorite

An Economic Overview of Chronic Obstructive Pulmonary Disease

By Ruchlin H.S.  

PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. : 623-642

Adis International

Access to resources Recommend Favorite

A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease

By Menn Petra   Leidl Reiner   Holle Rolf  

PharmacoEconomics, Vol. 30, Iss. 9, 2012-09 ,pp. : 825-840

Adis International

Access to resources Recommend Favorite

Immunologic Impact of Nutrient Depletion in Chronic Obstructive Pulmonary Disease

By  

Current Drug Targets, Vol. 12, Iss. 4, 2011-04 ,pp. : 489-500

Bentham Science Publishers

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite